Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: Sanofi | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: Sanofi

Revenues up 7% in the quarter

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Sanofi

4Q Revenues: €9.1 billion (+7%)

4Q Earnings: €1.8 billion (+1%)

FY Revenues: €33.8 billion (+3%)

FY Earnings: €6.8 billion (+2%)

Comments: Diabetes division sales increased 11% in the quarter to €2.0 billion, driven by Lantus, up 11% to €1.8 billion. Genzyme sales grew 22% to €746 million boosted by MS drug Aubagio (€146 million, up 99%). Sanofi Pasteur sales increased 16% to €1.2 billion driven by influenza vaccines in the U.S. and Emerging Markets as well as the continued recovery of Pentacel in the U.S. Consumer Healthcare sales were €817 million in the quarter, up 14%. Animal Health sales were up 12% to €507 million driven by the launch of NexGard.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters